Dr. Aditi Chatterjee earned her Ph.D. from CSIR-Central Drug Research Institute, India in 2018. Her Ph.D. work focused on the signaling of tyrosine phosphatase of Mycobacterium tuberculosis. Upon completion of her Ph.D., she joined University of California San Francisco for her postdoc. She worked in the laboratory of Dr. Som S Chatterjee where she focused on the role of Serine threonine kinase of Staphylococcus aureus in overcoming beta-lactam resistance in the bacteria. She moved with the same lab to University of Maryland Baltimore in 2019 and continued her work on S. aureus. In 2020 she moved to the field of cancer and is now working with Dr. Maria R Baer as a Research Associate at the same university and her interest still remains in kinases and drug resistance. Her work in Dr. Baer’s lab focusses on different mechanisms to overcome resistance in Acute Myeloid Leukemia with FLT3-ITD mutations.